Potential for Nuclear Medicine Therapy for Glioblastoma Treatment

Glioblastoma is the most common malignant adult brain tumor and has a very poor patient prognosis. The mean survival for highly proliferative glioblastoma is only 10 to 14 months despite an aggressive current therapeutic approach known as Stupp’s protocol, which consists of debulking surgery followe...

Descripción completa

Detalles Bibliográficos
Autores principales: Bailly, Clément, Vidal, Aurelien, Bonnemaire, Coralie, Kraeber-Bodéré, Françoise, Chérel, Michel, Pallardy, Amandine, Rousseau, Caroline, Garcion, Emmanuel, Lacoeuille, Franck, Hindré, François, Valable, Samuel, Bernaudin, Myriam, Bodet-Milin, Caroline, Bourgeois, Mickaël
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2019
Materias:
Pharmacology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6637301/
https://www.ncbi.nlm.nih.gov/pubmed/31354487
http://dx.doi.org/10.3389/fphar.2019.00772

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6637301/
https://www.ncbi.nlm.nih.gov/pubmed/31354487
http://dx.doi.org/10.3389/fphar.2019.00772

Ejemplares similares